KCKuddusi Cengiz

Kuddusi Cengiz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kuddusi Cengiz has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Comparison Of Atherosclerotic Risk Factors In Patients With Secondary Amylodosis And Nephrotic Syndrome

    by Osman Cure, Kuddusi Cengiz

    Objectivewe aimed to compare atherosclerotic risk factors in patients with secondary amyloid and nephrotic syndrome with proteinuria.Method In the nephrology outpatient clinic, patients with nephrotic syndrome clinic and proteinuria underwent diagnostic biopsy of the kidney and other tissues thought to be infiltrated with amyloidosis. Demographic, clinical, laboratory and biopsy results of the people included in the study were evaluated. ResultsA total of 89 people were included in the study (secondary amyloidosis: 12 female and 18 men, nephrotic syndrome: 12 female and 17 men, healthy control: 15 female and 15 men, mean age respectively: 46.5±14.2 year, 45.3±13.3 year, 45.4±5.7 year), Total cholesterol, triglyceride, low density lipoprotein cholesterol (LDL-C), lipoprotein a (Lp a), apo-lipoprotein Al (apo Al), apo-lipoprotein B (apo B), apo-lipoprotein E (apo E), C- reactive protein (CRP) and fibrinogen levels in nephrotic syndrome and secondary amylodosis patients were significantly higher than the control group whereas high density lipoprotein cholesterol (HDL-C) levels were lower (p<0.01). When nephrotic syndrome and secondary amyloidosis patients were compared, total cholesterol, triglyceride, LDL-C, HDL-C, apo Al, apo B and apo E levels were higher in the nephrotic syndrome group compared to the secondary amyloidosis group (p0.05).ConclusionOur data showed that atherosclerotic risk factors were significantly higher in patients with nephrotic syndrome and secondary amyloidosis. Patients with amyloidosis should be closely monitored for other atherosiderotic risk factors as well as amyloid accumulated in the organs

  • Open Access

    General Internal Medicine VI

    by Cundullah Torun, Osman Cure, Kuddusi Cengiz, Kadir İlKkılıç, Ekrem Algun, Mustafa Metin Donma, Sibel Çiğdem Tuncer, Nilgün Altan, Aylin Sepici Dinçel, Funda Kosava, et al.

    Epidemiology, Microbiology and Diagnosis of Helicobacter Pylori Cundullah TORUN Comparison Of Atherosclerotic Risk Factors In Patients With Secondary Amylodosis And Nephrotic Syndrome Osman CURE Kuddusi CENGIZ Investigation of the Frequency and Causes of Anemia in Patients With Hypothyroidism in The Eastern Blacksea Region Kadir ILKKILIC Ekrem ALGUN Complete Blood Cell Count and Hepatokines as Inflammatory Markers in Obesity Mustafa Metin DONMA Effects of Insulin and Thyroid Hormones on Antioxidant Enzymes and Lipid Peroxidation Products in Diabetes Mellitus Sibel Çiğdem TUNCER Nilgün ALTAN Aylin Sepici DİNÇEL Funda KOSAVA Atilla ENGİN Leyla MEMİŞ Cemile KOCA Nilgün KOCAMANOĞLU Gout Disease and Current Treatment Yusufcan YILMAZ Physiological Changes in the Elderly Feyza MUTLAY Factors Affecting Mortality and Morbidity in Non-Varicose Acute Upper Gastrointestinal System Bleeding Mustafa BAYDAR Bülent YILDIRIM The Distribution of Seroprevalence of Viral Hepatitis in Diyarbakir Province Berfin KADIROGLU Applications of Artificial Intelligence in Health Sciences Zehra KADIROGLU

  • Open Access

    Comparison of Cardiac Risk Factors in Patients with Nephrotic Syndrome and Secondary Amyloidosis

    by Osman Cüre, Teslime Ayaz, Kuddusi Cengi̇z

    Proteinuria is an independent risk factor for cardiovascular diseases and for the increment of atherosclerotic mortality. Atherosclerotic risk factors are well known in the various types of nephrotic syndrome but there are only few studies comparing the same risk factors between the secondary amyloidosis and nephrotic syndrome patients those have exactly same 24- hour protein levels in the urine. According to theliterature, recent comparative studies have not shown the etiological differences of atherosclerotic risk factors in these two disease groups. The aim of this study was to investigate the risk factors caused byproteinuria on development of atherosclerosis and to determine the differences in these disease groups those were well- matched in age, gender, arterial blood pressure levels, glomerular filtration rate (GFR) and body mass index. These patients groups were chosen to have exactly the same 24- hour protein levels in urine. 29 patients with nephrotic syndrome, 30 patients with secondary amyloidosis and 30 people of control group were taken to the trial. C- reactive protein (CRP), fibrinogen, cholesterol, triglyceride, low density lipoprotein (LDL-C), high density lipoprotein (HDL-C), lipoprotein -a [Lp(a)], apo- lipoprotein Al (apo Al), apolipoprotein B (apo B), apo- lipoprotein E (apo E), GFR and 24- hour protein in urine were compared between the patients and control groups. In the patients groups; cholesterol, triglyceride, LDL-C, Lp(a), apo A, apo B, apo E and fibrinogen levels were found much higher than the control group whereas HDL-C levels were lower (p

  • Should Tuberculosis Prophylaxis Be Given for the Chronically Dialyzed Patients?

    by Kuddusi Cengiz

    Until the middle of this century, tuberculosis was, in Dickens’ words, ‘a disease which medicine never cured, wealth warded off, or poverty could boast exemption from – which sometimes moves in giant strides, and sometimes at a tardy sluggish pace, but, slow or quick, is ever sure and certain’ [1]. Mycobacterium tuberculosis is an extremely successful pathogen that continues to thrive in developing countries and is re-emerging in the industrialized world. Globally, it remains a more frequent cause of death than any other infectious agent [2]. Approximately a third of the world’s population is infected with M. tuberculosis, and the World Health Organization estimated that in 1996 there were 8 million new cases of tuberculosis and 3 million deaths from the disease [2]. The sinister synergy between this disease of antiquity and the newer pathogen human immunodeficiency virus is responsible for the death of about a third of all patients with AIDS in Africa [3].